These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27842758)

  • 1. Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient.
    Choi HJ; Kil MC; Choi JY; Kim SJ; Park KS; Kim YJ; Ko KS
    Int J Antimicrob Agents; 2017 Jan; 49(1):102-106. PubMed ID: 27842758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
    J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
    Savari M; Ekrami A; Shoja S; Bahador A
    Folia Microbiol (Praha); 2017 Sep; 62(5):373-379. PubMed ID: 28238067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of carbapenem-resistant Acinetobacter baumannii ST787 in clinical isolates from blood in a tertiary teaching hospital in Northern Taiwan.
    Hu YF; Hou CJ; Kuo CF; Wang NY; Wu AY; Leung CH; Liu CP; Yeh HI
    J Microbiol Immunol Infect; 2017 Oct; 50(5):640-645. PubMed ID: 28711441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
    Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
    J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin.
    Rodriguez CH; Bombicino K; Granados G; Nastro M; Vay C; Famiglietti A
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):188-91. PubMed ID: 19748431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
    Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of imipenem/colistin methanesulfonate combinations against imipenem-nonsusceptible multidrug-resistant Acinetobacter baumannii.
    Leu HS; Ye JJ; Lee MH; Su LH; Huang PY; Wu TL; Huang CT
    J Microbiol Immunol Infect; 2014 Oct; 47(5):406-11. PubMed ID: 23834782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
    Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
    J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.
    Le Minh V; Thi Khanh Nhu N; Vinh Phat V; Thompson C; Huong Lan NP; Thieu Nga TV; Thanh Tam PT; Tuyen HT; Hoang Nhu TD; Van Hao N; Thi Loan H; Minh Yen L; Parry CM; Trung Nghia HD; Campbell JI; Hien TT; Thwaites L; Thwaites G; Van Vinh Chau N; Baker S
    J Med Microbiol; 2015 Oct; 64(10):1162-1169. PubMed ID: 26297024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
    Chuang YC; Sheng WH; Lauderdale TL; Li SY; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2014 Aug; 47(4):324-32. PubMed ID: 23726465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.